Working… Menu
Trial record 4 of 46 for:    Asklepios BioPharmaceutical

Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients (SECURE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02129439
Recruitment Status : Completed
First Posted : May 2, 2014
Last Update Posted : March 9, 2018
Information provided by (Responsible Party):
Sterna Biologicals GmbH & Co. KG

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 22, 2017
Actual Study Completion Date : June 22, 2017